John H. Rex
Hoofd Techniek/Wetenschap/O&O bij F2G Ltd.
Actieve functies van John H. Rex
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Directeur/Bestuurslid | - | - |
| Hoofd Techniek/Wetenschap/O&O | 02-11-2016 | - | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Consultant / Adviseur | 01-11-2015 | - |
| Private Equity Investor | 01-11-2015 | - |
Loopbaan van John H. Rex
Eerdere bekende functies van John H. Rex
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
AstraZeneca GmbH
 AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | Corporate Officer/Principal | 01-01-2003 | 01-10-2016 |
CLSI, Inc.
 CLSI, Inc. Information Technology ServicesTechnology Services CLSI, Inc. provides computer support services. CLSI was acquired by Infor Global Solutions (Canada) Ltd. from TBG, Inc. on December 10, 1992. | Directeur/Bestuurslid | - | - |
Opleiding van John H. Rex
| Rice University | Undergraduate Degree |
| Baylor College of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 3 |
| Duitsland | 2 |
Operationeel
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
AstraZeneca GmbH
AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | Health Technology |
CLSI, Inc.
CLSI, Inc. Information Technology ServicesTechnology Services CLSI, Inc. provides computer support services. CLSI was acquired by Infor Global Solutions (Canada) Ltd. from TBG, Inc. on December 10, 1992. | Technology Services |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
- Beurs
- Insiders
- John H. Rex
- Ervaring
